— Know what they know.
Not Investment Advice
Also trades as: CURA.TO (TSX) · $vol 3M · CURA.CN (CNQ) · $vol 2M

CURLF OTC

Curaleaf Holdings, Inc.
1W: -10.1% 1M: -0.5% 3M: +4.7% YTD: +26.6% 1Y: +14.0% 3Y: -25.5% 5Y: -73.0%
$9.95
-0.33 (-3.24%)
 
Weekly Expected Move ±8.5%
$8 $9 $10 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2.6B mcap · 169M float · 0.169% daily turnover · Short 34% of daily vol

Cash Flow Trends

Operating Cash Flow
$140M -9.3% ▼
5Y CAGR: +62.6%
Capital Expenditures
$65M +27.2% ▲
5Y CAGR: -12.6%
Free Cash Flow
$76M +14.7% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$6M -136.5% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$109M-$377M-$239M-$221M-$251M
Depreciation & Amort.$133M$176M$212M$238M$144M
Stock-Based Comp.$39M$28M$20M$0$0
Change in Working Capital-$89M$110M$34M$99M$122M
Other Non-Cash Items-$34M$134M$78M$91M$125M
Operating Cash Flow-$34M$46M$75M$155M$140M
— Investing Activities —
Capital Expenditures-$172M-$138M-$65M-$93M-$66M
Acquisitions (Net)$7M-$93M-$4M-$3M$0
Investment Purchases-$30M-$11M$0-$674K$0
Investment Sales$30M$11M$0$8M$0
Other Investing$1M$3M-$10M-$131K-$6M
Investing Cash Flow-$164M-$229M-$79M-$89M-$72M
— Financing Activities —
Net Debt Issuance$179M$56M-$52M-$32M-$25M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$29M-$15M-$27M-$20M-$50M
Financing Cash Flow$425M$51M-$67M-$52M-$75M
Net Change in Cash$226M-$136M-$71M$16M-$6M
Cash End of Period$299M$163M$92M$107M$101M
Free Cash Flow-$206M-$92M$5M$66M$76M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms